Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Pharmacosmos
Pharmacosmos
Pharmacosmos is a pharmaceutical company specialized in treatment of iron deficiency anemia.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Monoferric
Ferric derisomaltose
2020-01-16
2029-2036
Iron-deficiency anemia
Cosela
Trilaciclib
2021-02-12
2031-2039
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Trilaciclib
non-small-cell lung carcinoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
pancreatic neoplasms
,
osteosarcoma
,
carcinoma
,
neoplasms
,
hemangiosarcoma
,
pathologic complete response
,
urologic neoplasms
,
transitional cell carcinoma
,
chemotherapy-induced febrile neutropenia
,
neutropenia
,
endometrial neoplasms
,
uterine cervical neoplasms
,
esophageal neoplasms
,
large b-cell lymphoma diffuse
,
sarcoma
,
ewing sarcoma
,
head and neck neoplasms
,
biliary tract neoplasms
,
breast neoplasms
,
triple negative breast neoplasms
,
neoplasm metastasis
,
urinary bladder neoplasms
,
colorectal neoplasms
,
small cell lung carcinoma
,
lung neoplasms
,
esophageal squamous cell carcinoma
Ferric derisomaltose
deficiency diseases
,
hypophosphatemia
,
chronic renal insufficiency
,
kidney diseases
,
female genital neoplasms
,
iron-deficiency anemia
,
iron deficiencies
,
anemia
,
heart failure
,
left ventricular dysfunction
,
congenital abnormalities
,
spinal dysraphism
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use